Phreesia hit its profitability inflection just as Network Solutions slowed—creating a rare “cash-flowing healthcare intake leader at a floor multiple” setup if AccessOne scales.
Overview
Phreesia is a key U.S. healthcare infrastructure software platform focused on digitizing the patient intake experience—administrative, clinical, and financial interactions that occur before and during visits. By FY2026, it supported ~180M annual patient visits (~1 in 6 U.S. ambulatory visits), giving it meaningful scale in a ~$24B TAM while addressing a broader pool of administrative waste. Revenue is generated through (1) SaaS subscriptions from healthcare provider clients for modules like mobile check-in and screenings, (2) payment processing and now financing following the AccessOne acquisition, and (3) Network Solutions that lets pharma deliver targeted, consent-based content at the moment of care. FY2026 was the profitability inflection: $480.6M revenue (+~14%), first full-year GAAP net income ($2.3M), >$100M Adjusted EBITDA, and $54.4M free cash flow. The key near-term overhang is a FY2027 revenue growth slowdown driven by pharma marketing headwinds, but the company’s embedded integrations, switching costs, and expanding financial platform support a durable long-term thesis.